From: Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study
HR (95 % CI)
P
eGFRa
0.55(0.39-0.77)
<0.001
Proteinuriab
1.54(1.07-2.21)
0.02
Anemia
2.28(1.04-4.99)
0.04
TAIFc
1.48(1.08-2.03)
Global glomerulosclerosisc
1.33(1.12-1.58)
0.001